How are HbA1c and menopause related?

Menopause is characterized by a decline in estrogen, which reduces insulin sensitivity and alters glucose metabolism, often leading to elevated HbA1c levels. Epidemiological studies consistently show that postmenopausal women have higher HbA1c compared to premenopausal women, independent of age. The shift toward central adiposity and increased inflammatory markers further promote insulin resistance. However, the relationship is modulated by lifestyle, genetics, and hormone therapy. Some evidence suggests that hormone replacement therapy (HRT) may lower HbA1c, but results are mixed and depend on timing and type of therapy. Importantly, HbA1c reflects average glycemia over 2–3 months, but perimenopausal fluctuations (hot flashes, sleep disruption) can indirectly affect glucose control. Elevated HbA1c in menopause is clinically relevant as it increases cardiovascular risk. Yet, HbA1c alone should not be used for diagnosis without fasting glucose or OGTT, especially in women with anemia or hemoglobin variants. The provided context does not contain direct information on this topic; the answer is based on established medical knowledge.